TWD 33.75
(-10.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 207 Million TWD | 156.33% |
2022 | -367.51 Million TWD | -180.29% |
2021 | 457.71 Million TWD | 584.18% |
2020 | -94.53 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 458.54 Million TWD | -2.37% |
2024 Q1 | 469.67 Million TWD | 126.89% |
2023 Q4 | 207 Million TWD | -39.95% |
2023 FY | 207 Million TWD | 156.33% |
2023 Q1 | -200.73 Million TWD | 0.0% |
2023 Q3 | 344.7 Million TWD | 473.64% |
2023 Q2 | -92.25 Million TWD | 54.04% |
2022 FY | -367.51 Million TWD | -180.29% |
2022 Q4 | - TWD | 0.0% |
2021 FY | 457.71 Million TWD | 584.18% |
2020 FY | -94.53 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 368.689% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 178.362% |
Level Biotechnology Inc. | -453.9 Million TWD | 145.606% |
Sagittarius Life Science Corp | -120.57 Million TWD | 271.692% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 205.403% |
TaiMed Biologics Inc. | 499.84 Million TWD | 58.586% |
GlycoNex Incorporation | -148.56 Million TWD | 239.337% |
VBI | -25.31 Million TWD | 917.7% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | -414.104% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | -50.012% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 178.836% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -576.987% |
Visgeneer Inc. | 31.28 Million TWD | -561.709% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 130.415% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 254.194% |
Neith Corporation | -150.31 Million TWD | 237.72% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 66.694% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 459.029% |
Enimmune corporation | -314.15 Million TWD | 165.893% |
TaiRx, Inc. | -147.86 Million TWD | 239.995% |
CHO Pharma, Inc. | -203.79 Million TWD | 201.579% |
EirGenix Inc. | -4.58 Billion TWD | 104.512% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 344.221% |
Sunny Pharmtech Inc. | 120.87 Million TWD | -71.264% |
Lin BioScience, Inc. | -3.21 Billion TWD | 106.432% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 165.217% |
Feng Chi Biotech Corp. | -19.81 Million TWD | 1144.814% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | -550.788% |
Lukas Biomedical Inc. | 50.75 Million TWD | -307.859% |
RBC Bioscience Corporation | 422.18 Million TWD | 50.967% |
BiOptic Inc. | 12.59 Million TWD | -1543.972% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 121.92% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 303.978% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 225.326% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 34.256% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 421.837% |
NaviFUS Corp. | -123.12 Million TWD | 268.124% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -179.549% |
Sinew Pharma Inc. | -160.34 Million TWD | 229.102% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 185.579% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 161.359% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 150.167% |
AP Biosciences Inc | -196.52 Million TWD | 205.333% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 69.944% |
3D Global Biotech Inc. | -11.43 Million TWD | 1909.994% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 124.95% |
Intech Biopharm Corporation | 1.35 Billion TWD | 84.749% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 149.896% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 198.887% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 243.893% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 162.627% |
TCI GENE Inc. | -689.25 Million TWD | 130.034% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 274.048% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 115.812% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -910.638% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 303.209% |
PharmaEngine, Inc. | -860.8 Million TWD | 124.048% |
Savior Lifetec Corporation | -812.54 Million TWD | 125.477% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 169.01% |
OBI Pharma, Inc. | -398.22 Million TWD | 151.983% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 156.65% |
Acepodia, Inc. | -6.02 Billion TWD | 103.439% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 106.085% |